Abstract
Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease characterized by the production of autoantibodies generating systemic inflammation and multiorgan involvement. In this study we describe the classificatory criteria, activity index, organ damage index and treatment of patients treated at the headquarters of the Guatemalan Association Against Rheumatic Diseases (AGAR) located in Guatemala City
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.